Cargando…

Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization

Among the different ways to reduce the secondary effects of antineoplastic drugs in cancer treatment, the use of nanoparticles has demonstrated good results due to the protection of the drug and the possibility of releasing compounds to a specific therapeutic target. The α-isoform of the folate rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Relimpio, Ana María, Benito, Marta, Pérez-Izquierdo, Elena, Teijón, César, Olmo, Rosa María, Blanco, María Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272094/
https://www.ncbi.nlm.nih.gov/pubmed/34202848
http://dx.doi.org/10.3390/polym13132083
_version_ 1783721144619106304
author Martínez-Relimpio, Ana María
Benito, Marta
Pérez-Izquierdo, Elena
Teijón, César
Olmo, Rosa María
Blanco, María Dolores
author_facet Martínez-Relimpio, Ana María
Benito, Marta
Pérez-Izquierdo, Elena
Teijón, César
Olmo, Rosa María
Blanco, María Dolores
author_sort Martínez-Relimpio, Ana María
collection PubMed
description Among the different ways to reduce the secondary effects of antineoplastic drugs in cancer treatment, the use of nanoparticles has demonstrated good results due to the protection of the drug and the possibility of releasing compounds to a specific therapeutic target. The α-isoform of the folate receptor (FR) is overexpressed on a significant number of human cancers; therefore, folate-targeted crosslinked nanoparticles based on BSA and alginate mixtures and loaded with paclitaxel (PTX) have been prepared to maximize the proven antineoplastic activity of the drug against solid tumors. Nanometric-range-sized particles (169 ± 28 nm–296 ± 57 nm), with negative Z-potential values (between −0.12 ± 0.04 and −94.1± 0.4), were synthesized, and the loaded PTX (2.63 ± 0.19–3.56 ±0.13 µg PTX/mg Np) was sustainably released for 23 and 27 h. Three cell lines (MCF-7, MDA-MB-231 and HeLa) were selected to test the efficacy of the folate-targeted PTX-loaded BSA/ALG nanocarriers. The presence of FR on the cell membrane led to a significantly larger uptake of BSA/ALG–Fol nanoparticles compared with the equivalent nanoparticles without folic acid on their surface. The cell viability results demonstrated a cytocompatibility of unloaded nanoparticle–Fol and a gradual decrease in cell viability after treatment with PTX-loaded nanoparticle–Fol due to the sustainable PTX release.
format Online
Article
Text
id pubmed-8272094
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82720942021-07-11 Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization Martínez-Relimpio, Ana María Benito, Marta Pérez-Izquierdo, Elena Teijón, César Olmo, Rosa María Blanco, María Dolores Polymers (Basel) Article Among the different ways to reduce the secondary effects of antineoplastic drugs in cancer treatment, the use of nanoparticles has demonstrated good results due to the protection of the drug and the possibility of releasing compounds to a specific therapeutic target. The α-isoform of the folate receptor (FR) is overexpressed on a significant number of human cancers; therefore, folate-targeted crosslinked nanoparticles based on BSA and alginate mixtures and loaded with paclitaxel (PTX) have been prepared to maximize the proven antineoplastic activity of the drug against solid tumors. Nanometric-range-sized particles (169 ± 28 nm–296 ± 57 nm), with negative Z-potential values (between −0.12 ± 0.04 and −94.1± 0.4), were synthesized, and the loaded PTX (2.63 ± 0.19–3.56 ±0.13 µg PTX/mg Np) was sustainably released for 23 and 27 h. Three cell lines (MCF-7, MDA-MB-231 and HeLa) were selected to test the efficacy of the folate-targeted PTX-loaded BSA/ALG nanocarriers. The presence of FR on the cell membrane led to a significantly larger uptake of BSA/ALG–Fol nanoparticles compared with the equivalent nanoparticles without folic acid on their surface. The cell viability results demonstrated a cytocompatibility of unloaded nanoparticle–Fol and a gradual decrease in cell viability after treatment with PTX-loaded nanoparticle–Fol due to the sustainable PTX release. MDPI 2021-06-24 /pmc/articles/PMC8272094/ /pubmed/34202848 http://dx.doi.org/10.3390/polym13132083 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martínez-Relimpio, Ana María
Benito, Marta
Pérez-Izquierdo, Elena
Teijón, César
Olmo, Rosa María
Blanco, María Dolores
Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
title Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
title_full Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
title_fullStr Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
title_full_unstemmed Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
title_short Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
title_sort paclitaxel-loaded folate-targeted albumin-alginate nanoparticles crosslinked with ethylenediamine. synthesis and in vitro characterization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272094/
https://www.ncbi.nlm.nih.gov/pubmed/34202848
http://dx.doi.org/10.3390/polym13132083
work_keys_str_mv AT martinezrelimpioanamaria paclitaxelloadedfolatetargetedalbuminalginatenanoparticlescrosslinkedwithethylenediaminesynthesisandinvitrocharacterization
AT benitomarta paclitaxelloadedfolatetargetedalbuminalginatenanoparticlescrosslinkedwithethylenediaminesynthesisandinvitrocharacterization
AT perezizquierdoelena paclitaxelloadedfolatetargetedalbuminalginatenanoparticlescrosslinkedwithethylenediaminesynthesisandinvitrocharacterization
AT teijoncesar paclitaxelloadedfolatetargetedalbuminalginatenanoparticlescrosslinkedwithethylenediaminesynthesisandinvitrocharacterization
AT olmorosamaria paclitaxelloadedfolatetargetedalbuminalginatenanoparticlescrosslinkedwithethylenediaminesynthesisandinvitrocharacterization
AT blancomariadolores paclitaxelloadedfolatetargetedalbuminalginatenanoparticlescrosslinkedwithethylenediaminesynthesisandinvitrocharacterization